Unmasking Hemiplegic Migraine: A Diagnostic Dilemma in the Shadow of Stroke
Abstract
A rare presentation of a migraine headache is hemiplegic migraine (HM), which can clinically imitate other conditions, including transient ischemic attack (TIA) and cerebrovascular accident (CVA), with unilateral muscle weakness or hemiplegia, making accurate diagnosis challenging. We present a 41-year-old male patient who was admitted with symptoms of a unilateral occipital headache, expressive aphasia, and right-sided motor weakness on two occasions over six days to two different hospitals. CT with and without contrast, echocardiogram, troponin I, EKG, and MRI results were normal. The patient was seen and discharged by neurology to be treated for headaches as an outpatient with butalbital-acetaminophen-caffeine. A diagnosis of sporadic HM was made after a thorough history by the primary care provider and managed conservatively with verapamil. This case highlights the critical role of primary care in synthesizing clinical information and history to establish an accurate diagnosis, underscoring the need for detailed patient evaluation. Raising awareness of HM as part of the differential diagnosis is vital after ruling out life-threatening conditions through imaging and clinical evaluation.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.